Dr. Fredika Robertson   Understanding Inflammatory Breast Cancer
An Interview with Dr. Fredika Robertson

Research Focus:  Understanding the molecular basis for Inflammatory Breast Cancer (IBC) and  the role that cancer stem cells play in the metastasis that often occurs in patients exhibiting this disease

Experimental Model: 3D Tumor Spheroid Models

Research Position & Institution:  Professor in the Department of Experimental Therapeutics and Laboratory of Translational Therapeutics, Morgan Welch Inflammatory Breast Cancer Research Program at the University of Texas MD Anderson Cancer Center in Houston, Texas.

In this interview, Dr. Robertson discusses the effort in her laboratory to identify therapeutics that target inflammatory breast cancer. Her research has implications for potential clinical approaches to effectively increase the survival from this type of breast cancer that is responsible for a very high percentage of the >40,000 breast cancer–related deaths that occur annually.

  • Watch the interview videos below

Inflammatory Breast Cancer—The Disease


Watch the video to learn more about Dr. Fredika Robertson’s cancer research and breast cancer as a disease.

Inflammatory Breast Cancer—The Biology


Watch the video to discover how Dr. Fredika Robertson’s 3D models are advancing cancer research.

Learn More

The Myth about Breast Cancer

Did you know? It is a myth that you have to have a lump to have breast cancer. Find out more about inflammatory breast cancer below.

 

Molecular Probes® Technologies

Learn more about the  technologies Dr. Robertson uses in her cancer research.

 

See More Videos

See more videos about Susan G. Komen and American Airlines, including the Promise Grant award supporting IBC and support for other breast cancer research.


Research Publications

Gain even more insight to Dr. Robertson's cancer research by taking a look at this collection of peer-reviewed research publications.

The Data

Tumor Emboli Staining
 
Immunofluorescent staining of cells from the Mary-X model of inflammatory breast cancer, which form tumor emboli, stained with anti–E-cadherin antibodies (green fluorescence). These tumor emboli invade skin and lymph nodes by lymphovascular invasion, denoted by the lymphovascular endothelium stained with podoplanin antibodies (red fluorescence) that encircle the tumor emboli. Credit for the images goes to Dr. Zaiming Ye, Dr. Savitri Kirshnamurthy, and Moishia C. Wright.